PETVIVO HOLDINGS INC (PETV) Stock Price, Quote, News and Overview
NASDAQ:PETV - Nasdaq - US7168174081 - Common Stock - Currency: USD
PETV Quote, Performance and Key Statistics
0.969
-0.07 (-7%)
The current stock price of PETV is 0.969 USD. In the past month the price decreased by -10.28%. In the past year, price decreased by -64.63%.
PETV Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
| ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
| BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
| SYK | STRYKER CORP | 31.4 | 145.92B | ||
| MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
| BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
| IDXX | IDEXX LABORATORIES INC | 40.25 | 37.07B | ||
| DXCM | DEXCOM INC | 53.81 | 34.68B | ||
| RMD | RESMED INC | 26.21 | 34.03B | ||
| PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B |
Related stock screener links
About PETV
Company Profile
PetVivo Holdings, Inc. is a veterinary biotech and biomedical device company. The company is headquartered in Edina, Minnesota and currently employs 25 full-time employees. The company went IPO on 2012-07-10. The firm is focused on the manufacturing, commercialization, and licensing of medical devices and therapeutics for animals. The Company’s lead product Spryng with OsteoCushion Technology, is a veterinarian-administered, intraarticular injection for the management of lameness and other joint afflictions, such as osteoarthritis in dogs and horses. The firm is primarily engaged in the business of commercializing and licensing products in the veterinary market to treat and/or manage afflictions of companion animals, such as dogs and horses. Its products are derived from biomaterials that simulate a body’s cellular tissue by virtue of their reliance upon natural protein and carbohydrate compositions, which incorporate such tissue building blocks as collagen, elastin, and proteoglycans such as heparin. The firm has a pipeline of therapeutic devices for both veterinary and human clinical applications.
Company Info
PETVIVO HOLDINGS INC
5251 Edina Industrial Blvd
Edina MINNESOTA US
CEO: John Lai
Employees: 25
Company Website: https://petvivo.com/
Phone: 19522174952
PETVIVO HOLDINGS INC / PETV FAQ
What is the stock price of PETVIVO HOLDINGS INC today?
The current stock price of PETV is 0.969 USD. The price decreased by -7% in the last trading session.
What is the ticker symbol for PETVIVO HOLDINGS INC stock?
The exchange symbol of PETVIVO HOLDINGS INC is PETV and it is listed on the Nasdaq exchange.
On which exchange is PETV stock listed?
PETV stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PETVIVO HOLDINGS INC stock?
7 analysts have analysed PETV and the average price target is 7.14 USD. This implies a price increase of 636.84% is expected in the next year compared to the current price of 0.969. Check the PETVIVO HOLDINGS INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PETVIVO HOLDINGS INC worth?
PETVIVO HOLDINGS INC (PETV) has a market capitalization of 16.25M USD. This makes PETV a Nano Cap stock.
How many employees does PETVIVO HOLDINGS INC have?
PETVIVO HOLDINGS INC (PETV) currently has 25 employees.
What are the support and resistance levels for PETVIVO HOLDINGS INC (PETV) stock?
PETVIVO HOLDINGS INC (PETV) has a resistance level at 1.03. Check the full technical report for a detailed analysis of PETV support and resistance levels.
Should I buy PETVIVO HOLDINGS INC (PETV) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PETV, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PETV, evaluating the profitability, health, valuation and growth aspects
- PETVIVO HOLDINGS INC (PETV) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PETVIVO HOLDINGS INC (PETV) Sales and EPS estimates to see what analysts future expectations are.
- PETVIVO HOLDINGS INC (PETV) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PETVIVO HOLDINGS INC (PETV) Insider and Institutional Ownership to learn about the owners and their transactions.
- PETVIVO HOLDINGS INC (PETV) Stock Chart to make your own analysis
- PETVIVO HOLDINGS INC (PETV) Latest news and press-releases to stay up to date.
Does PETVIVO HOLDINGS INC (PETV) stock pay dividends?
PETV does not pay a dividend.
When does PETVIVO HOLDINGS INC (PETV) report earnings?
PETVIVO HOLDINGS INC (PETV) will report earnings on 2024-06-27, after the market close.
What is the Price/Earnings (PE) ratio of PETVIVO HOLDINGS INC (PETV)?
PETVIVO HOLDINGS INC (PETV) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.81).
What is the Short Interest ratio of PETVIVO HOLDINGS INC (PETV) stock?
The outstanding short interest for PETVIVO HOLDINGS INC (PETV) is 0.78% of its float. Check the ownership tab for more information on the PETV short interest.
PETV Technical Analysis
PETV Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to PETV. PETV may be in some trouble as it scores bad on both profitability and health.
PETV Financial Highlights
Over the last trailing twelve months PETV reported a non-GAAP Earnings per Share(EPS) of -0.81. The EPS decreased by -6.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -292.88% | ||
| ROE | -1187.69% | ||
| Debt/Equity | 0.16 |
PETV Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 83% to PETV. The Buy consensus is the average rating of analysts ratings from 7 analysts.